Correlation Between Hyperfine and Neuropace
Can any of the company-specific risk be diversified away by investing in both Hyperfine and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyperfine and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hyperfine and Neuropace, you can compare the effects of market volatilities on Hyperfine and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyperfine with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyperfine and Neuropace.
Diversification Opportunities for Hyperfine and Neuropace
Very good diversification
The 3 months correlation between Hyperfine and Neuropace is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Hyperfine and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Hyperfine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyperfine are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Hyperfine i.e., Hyperfine and Neuropace go up and down completely randomly.
Pair Corralation between Hyperfine and Neuropace
Given the investment horizon of 90 days Hyperfine is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Hyperfine is 1.15 times less risky than Neuropace. The stock trades about -0.01 of its potential returns per unit of risk. The Neuropace is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 426.00 in Neuropace on September 2, 2024 and sell it today you would earn a total of 634.00 from holding Neuropace or generate 148.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hyperfine vs. Neuropace
Performance |
| Timeline |
| Hyperfine |
| Neuropace |
Hyperfine and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hyperfine and Neuropace
The main advantage of trading using opposite Hyperfine and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyperfine position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| Hyperfine vs. Neuropace | Hyperfine vs. Orthopediatrics Corp | Hyperfine vs. Anika Therapeutics | Hyperfine vs. PAVmed Inc |
| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |